On a global scale, rotavirus causes over 500,000 deaths in children per year, particularly in emerging countries. Rotavirus is a contagious virus that can cause inflammation of the stomach and intestines – also identified as gastroenteritis. India has predicted that almost every child would experience an episode of rotavirus gastroenteritis by the age of 5. […]
Read More
Access to large markets where clinical trials that can investigate real patient needs, and do so in a rapid fashion, is invaluable for clinical research organisations. One such example of George Clinical rapid and access to huge markets took place in China, where diabetes patients numbered up to 90 million in 2010, and the most […]
Read More
BEIJING – October 15, 2016 – George Clinical welcomes the establishment of the Heart Health Research Center, a collaborative initiative developed by Cardio Union, an emerging multi-disciplinary healthcare organization and George Clinical’s partner in research, The George Institute for Global Health. The Heart Health Research Center (HHRC) will help to address the growing burden of […]
Read More
Either because of financial, legal or operational reasons, many companies including those in healthcare, are still stuck in the paper world when it comes to data and document management. Now that technology has become so much more advanced, switching to electronic health data format has a slew of advantages and benefits that can’t and shouldn’t […]
Read More
You likely have heard of COPD or Chronic Obstructive Pulmonary Disorder, as it is the 3rd most frequent cause of death in the world. This is an area of focus of our research because as prominent as this disease is, the cause of the disease in a large percentage of patients remains unknown. Diagnosis is […]
Read More
George Clinical, a leading Asia-Pacific CRO, have now achieved Medidata Rave® accreditation. Adding this platform to George Clinical’s robust stable of electronic data collection systems will allow George Clinical to further enhance the clinical data collection process for a broader range of customers. Headquartered in Sydney with 260 staff operating in 15 countires. George Clinical provides a full […]
Read More
Effective 2nd August 2016, the Central Drugs Standard Control Organization (CDSCO) India released new circulars in relation to the conduct of clinical trials. These new circulars have modified the trial requirements for sponsors wishing to conduct clinical trials in India. Furthermore, the CDSCO have addressed matters that may assist in reducing clinical trial timelines and […]
Read More
High blood pressure, or hypertension, can be defined as the flow of blood through the arteries being pushed against the inside of the artery walls. The more pressure the blood exerts on the artery walls, the higher the blood pressure. Hypertension has been labelled the silent killer – as it rarely has symptoms. As such, […]
Read More
After careful selection and consideration, George Clinical’s (GC) Evon Hui of the Hong Kong office has accepted the position of Associate Director, Business Operations, East Asia (EA) and will be reporting directly to Marisa Petersen, Chief Executive Officer of GC. Evon joined GC in November 2012 as the Regional Clinical Operations Manager (COM) for the […]
Read More
From the 30th March – 1 April 2016, George Clinical will be exhibiting at the largest Bio exhibition in Asia – Bio Korea 2016, held in Seoul. BioKorea, established in 2006, has grown to be one of Asia’s premier events for global biotech industry. This year marks the 11th anniversary for this conference. BioKorea consists […]
Read More
